High materiality7/10
Kazia Therapeutics price target raised to $40 from $34 at BTIG
Why it may matterVerify against the original reporting
Upside potential implied by target raise.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
BTIG raises Kazia Therapeutics target to $40 from $34; current price $13.04; implies substantial upside.
- BTIG target $40; current price $13.04; upside potential.
Key facts
- 01
Target: $40
- 02
Posted price: $13.04
- 03
Analyst firm: BTIG
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.